Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page
- CheckyesterdayChange DetectedA new page revision v3.5.0 was added and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page header now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2, indicating a minor update. No changes to study details, eligibility criteria, or locations.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page shows a minor revision update: v3.4.1 was added and v3.4.0 was removed, with no visible changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a glossary toggle and updated minor metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act data) and the revision tag to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check66 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing v3.3.3; this minor housekeeping update does not affect trial content or participation details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.